Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,081,818
  • Shares Outstanding, K 51,665
  • Annual Sales, $ 1,051 M
  • Annual Income, $ -37,150 K
  • 60-Month Beta 1.32
  • Price/Sales 2.91
  • Price/Cash Flow 12.18
  • Price/Book 3.70
Trade NUVA with:

Options Overview Details

View History
  • Implied Volatility 37.59%
  • Historical Volatility 29.90%
  • IV Percentile 21%
  • IV Rank 15.16%
  • IV High 103.03% on 12/30/20
  • IV Low 25.90% on 06/16/21
  • Put/Call Vol Ratio 0.04
  • Today's Volume 26
  • Volume Avg (30-Day) 951
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 3,769
  • Open Int (30-Day) 2,271

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.61
  • Number of Estimates 10
  • High Estimate 0.68
  • Low Estimate 0.54
  • Prior Year 0.54
  • Growth Rate Est. (year over year) +12.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.31 +8.72%
on 09/13/21
62.54 -2.11%
on 09/02/21
+2.52 (+4.29%)
since 08/20/21
3-Month
56.09 +9.15%
on 08/11/21
70.76 -13.48%
on 06/25/21
-6.93 (-10.17%)
since 06/22/21
52-Week
43.11 +42.01%
on 11/06/20
72.61 -15.69%
on 04/29/21
+10.19 (+19.97%)
since 09/22/20

Most Recent Stories

More News
NuVasive Partners with Scoliosis Research Society in Ongoing Double Diamond Sponsorship

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced...

NUVA : 61.22 (+2.63%)
NuVasive Simplify Cervical Disc Data Published In International Journal Of Spine Surgery

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced...

NUVA : 61.22 (+2.63%)
Berkeley Lights Announces Appointment of Dr. Siddhartha Kadia to the Board of Directors

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced that Siddhartha Kadia, Ph.D. joined the Berkeley Lights Board of Directors as an independent director, effective September...

BLI : 23.15 (-6.46%)
NUVA : 61.22 (+2.63%)
HZD.LN : 184.500 (unch)
Cervical Spine Surgery Market- Size and Growth, CAGR Value, Share and Revenues, Industry Trends, Business Strategies and Challenges till 2029

Research Nester released a report titled which delivers detailed overview of the global cervical spine surgery marketin terms of market segmentation by surgery type, end-user and region.

MDT : 128.91 (+0.84%)
SYK : 271.65 (+1.27%)
NUVA : 61.22 (+2.63%)
ZBH : 145.70 (+2.06%)
GMED : 79.57 (+1.21%)
BSX : 44.31 (+2.19%)
ABT : 124.65 (-0.38%)
NuVasive (NUVA) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

NUVA : 61.22 (+2.63%)
Cervical Spine Surgery Market- Overview, Opportunities, In-Depth Analysis, Segment and Forecast To 2029

Research Nester released a report titled which delivers detailed overview of the global cervical spine surgery marketin terms of market segmentation by surgery type, end-user and region.

MDT : 128.91 (+0.84%)
SYK : 271.65 (+1.27%)
NUVA : 61.22 (+2.63%)
ZBH : 145.70 (+2.06%)
GMED : 79.57 (+1.21%)
BSX : 44.31 (+2.19%)
ABT : 124.65 (-0.38%)
NuVasive Announces New Executive Leadership Roles

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced...

NUVA : 61.22 (+2.63%)
NuVasive to Present at Upcoming Investor Conference

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced...

NUVA : 61.22 (+2.63%)
NuVasive (NUVA) Down 6.1% Since Last Earnings Report: Can It Rebound?

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NUVA : 61.22 (+2.63%)
Amy Belt Raimundo to Join NuVasive Board of Directors

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced...

NUVA : 61.22 (+2.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical...

See More

Key Turning Points

3rd Resistance Point 64.64
2nd Resistance Point 63.22
1st Resistance Point 62.22
Last Price 61.22
1st Support Level 59.80
2nd Support Level 58.38
3rd Support Level 57.38

See More

52-Week High 72.61
Fibonacci 61.8% 61.34
Last Price 61.22
Fibonacci 50% 57.86
Fibonacci 38.2% 54.38
52-Week Low 43.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar